{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:23:59Z","timestamp":1791401039189,"version":"4.3.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Structure-based grouping of chemicals for targeted testing and read-across is an efficient way to reduce resources and animal usage. For substances of unknown or variable composition, complex reaction products, or biological materials (UVCBs), structure-based grouping is virtually impossible. Biology-based approaches such as metabolomics could provide a solution. Here, 15 steam-cracked distillates, registered in the EU through the Lower Olefins Aromatics Reach Consortium (LOA), as well as six of the major substance constituents, were tested in a 14-day rat oral gavage study, in line with the fundamental elements of the OECD 407 guideline, in combination with plasma metabolomics. Beyond signs of clinical toxicity, reduced body weight (gain), and food consumption, pathological investigations demonstrated the liver, thyroid, kidneys (males only), and hematological system to be the target organs. These targets were confirmed by metabolome pattern recognition, with no additional targets being identified. While classical toxicological parameters did not allow for a clear distinction between the substances, univariate and multivariate statistical analysis of the respective metabolomes allowed for the identification of several subclusters of biologically most similar substances. These groups were partly associated with the dominant (&gt;\u200950%) constituents of these UVCBs, i.e., indene and dicyclopentadiene. Despite minor differences in clustering results based on the two statistical analyses, a proposal can be made for the grouping of these UVCBs. Both analyses correctly clustered the chemically most similar compounds, increasing the confidence that this biological approach may provide a solution for the grouping of UVCBs.<\/jats:p>","DOI":"10.1007\/s00204-023-03638-6","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:14:08Z","timestamp":1706105648000},"page":"755-768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Utility of in vivo metabolomics to support read-across for UVCB substances under REACH"],"prefix":"10.1007","volume":"98","author":[{"given":"H.","family":"Kamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Aygun","family":"Kocabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Faulhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Synhaeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rushton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Flick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sperber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. G.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Penman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-9217","authenticated-orcid":false,"given":"B.","family":"van Ravenzwaay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rooseboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"3638_CR1","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1601251s","author":"N Ball","year":"2016","unstructured":"Ball N (2016) Toward Good Read-Across Practice (GRAP) guidance SUPPL. ALTEX. https:\/\/doi.org\/10.14573\/altex.1601251s","journal-title":"ALTEX"},{"issue":"3","key":"3638_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0192623309332992","volume":"37","author":"KJ Boudonck","year":"2009","unstructured":"Boudonck KJ et al (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol. 37(3):280\u2013292","journal-title":"Toxicol Pathol."},{"issue":"3","key":"3638_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1359-6446(03)02971-4","volume":"9","author":"A Bugrim","year":"2004","unstructured":"Bugrim A et al (2004) Early prediction of drug metabolism and toxicity: systems biology approach and modeling. Drug Discov Today 9(3):127\u2013135","journal-title":"Drug Discov Today"},{"key":"3638_CR4","unstructured":"ECHA (2014) The use of alternatives to testing on animals for the REACH Regulation\u202f: second report under Article 117(3) of the REACH Regulation. ECHA. http:\/\/echa.europa.eu\/documents\/10162\/13639\/alternatives_test_animals_2011_en.pdf"},{"key":"3638_CR5","doi-asserted-by":"publisher","unstructured":"ECHA. (2017a). Guidance for identification and naming of substances under REACH and CLP Version 2.1-Guidance for identification and naming of substances under REACH and CLP. https:\/\/doi.org\/10.2823\/538683","DOI":"10.2823\/538683"},{"key":"3638_CR6","doi-asserted-by":"publisher","unstructured":"ECHA. (2017b). Read-Across Assessment Framework (RAAF). https:\/\/doi.org\/10.2823\/619212","DOI":"10.2823\/619212"},{"key":"3638_CR7","doi-asserted-by":"publisher","unstructured":"ECHA. (2017c). Read-Across Assessment Framework (RAAF) Considerations on multi-constituent substances and UVCBs. https:\/\/doi.org\/10.2823\/794394","DOI":"10.2823\/794394"},{"issue":"7","key":"3638_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0192623312448935","volume":"40","author":"AP Hall","year":"2012","unstructured":"Hall AP, Elcombe CR, Foster JR, Harada T, Kaufmann W, Knippel A, K\u00fcttler K, Malarkey DE, Maronpot RR, Nishikawa A, Nolte T, Schulte A, Strauss V, York MJ (2012) Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes-conclusions from the 3rd international ESTP expert workshop. Toxicol Pathol. 40(7):971\u2013994. https:\/\/doi.org\/10.1177\/0192623312448935","journal-title":"Toxicol Pathol."},{"key":"3638_CR9","doi-asserted-by":"publisher","first-page":"105020","DOI":"10.1016\/J.YRTPH.2021.105020","volume":"125","author":"JA Harrill","year":"2021","unstructured":"Harrill JA, Viant MR, Yauk CL, Sachana M, Gant TW, Auerbach SS, Beger RD, Bouhifd M, O\u2019Brien J, Burgoon L, Caiment F, Carpi D, Chen T, Chorley BN, Colbourne J, Corvi R, Debrauwer L, O\u2019Donovan C, Ebbels TMD, Whelan M (2021) Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology. Regulatory Toxicol Pharmacol. 125:105020. https:\/\/doi.org\/10.1016\/J.YRTPH.2021.105020","journal-title":"Regulatory Toxicol Pharmacol."},{"issue":"18","key":"3638_CR10","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.4155\/bio.12.214","volume":"4","author":"H Kamp","year":"2012","unstructured":"Kamp H, Fabian E, Groeters S, Herold M, Krennrich G, Looser R, Mattes W, Mellert W, Prokoudine A, Ruiz-Noppinger P, Strauss V, Walk T, Wiemer J, Van Ravenzwaay B (2012) Application of in vivo metabolomics to preclinical\/toxicological studies: case study on phenytoin-induced systemic toxicity. Bioanalysis. 4(18):2291\u20132301. https:\/\/doi.org\/10.4155\/bio.12.214","journal-title":"Bioanalysis."},{"issue":"2","key":"3638_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/019262338901700206","volume":"17","author":"RM McClain","year":"1989","unstructured":"McClain RM (1989) The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: implications for thyroid gland neoplasia. Toxicol Pathol 17(2):294\u2013306","journal-title":"Toxicol Pathol"},{"issue":"2","key":"3638_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.toxlet.2013.12.010","volume":"225","author":"GA Montoya","year":"2014","unstructured":"Montoya GA, Strauss V, Fabian E, Kamp H, Mellert W, Walk T, Looser R, Herold M, Krennrich G, Peter E, van Ravenzwaay B (2014) Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. Toxicol Lett 225(2):240\u2013251. https:\/\/doi.org\/10.1016\/j.toxlet.2013.12.010","journal-title":"Toxicol Lett"},{"issue":"11","key":"3638_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson JK et al (1999) \u201cMetabonomics\u201d: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29(11):1181\u20131189","journal-title":"Xenobiotica."},{"issue":"6","key":"3638_CR14","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1039\/d0an02212h","volume":"146","author":"E Olesti","year":"2021","unstructured":"Olesti E, Gonz\u00e1lez-Ruiz V, Wilks MF, Boccard J, Rudaz S (2021) Approaches in metabolomics for regulatory toxicology applications. Analyst 146(6):1820\u20131834. https:\/\/doi.org\/10.1039\/d0an02212h","journal-title":"Analyst"},{"key":"3638_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104855","volume":"120","author":"CB Pestana","year":"2021","unstructured":"Pestana CB et al (2021) Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: a case study for repeated dose toxicity. Regular Toxicol Pharmacol 120:104855","journal-title":"Regular Toxicol Pharmacol"},{"issue":"2","key":"3638_CR16","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/toxsci\/kfi102","volume":"85","author":"DG Robertson","year":"2005","unstructured":"Robertson DG (2005) Metabonomics in toxicology: a review. Toxicol Sci 85(2):809\u2013822","journal-title":"Toxicol Sci"},{"key":"3638_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104442","volume-title":"Metabolomics as read-across tool: an example with 3-aminopropanol and 2-aminoethanol. Regulatory toxicology and pharmacology","author":"S Sperber","year":"2019","unstructured":"Sperber S, Wahl M, Berger F, Kamp H, Lemke O, Starck V, Walk T, Spitzer M, Ravenzwaay BV (2019) Metabolomics as read-across tool: an example with 3-aminopropanol and 2-aminoethanol. Regulatory toxicology and pharmacology, vol 108. Academic Press Inc, New York. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104442"},{"issue":"1","key":"3638_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.toxlet.2009.08.004","volume":"191","author":"V Strauss","year":"2009","unstructured":"Strauss V, Wiemer J, Leibold E, Kamp H, Walk T, Mellert W, Looser R, Prokoudine A, Fabian E, Krennrich G, Herold M, van Ravenzwaay B (2009) Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies. Toxicol Lett 191(1):88\u201395. https:\/\/doi.org\/10.1016\/j.toxlet.2009.08.004","journal-title":"Toxicol Lett"},{"issue":"6","key":"3638_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1289\/ehp.93101s639","volume":"101","author":"JA Swenberg","year":"1993","unstructured":"Swenberg JA (1993) alpha 2u globulin nephropathy review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ Health Perspect. 101(6):39\u201344","journal-title":"Environ Health Perspect."},{"issue":"2","key":"3638_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.mrgentox.2012.01.006","volume":"746","author":"B van Ravenzwaay","year":"2012","unstructured":"van Ravenzwaay B, Herold M, Kamp H, Kapp MD, Fabian E, Looser R, Krennrich G, Mellert W, Prokoudine A, Strauss V, Walk T, Wiemer J (2012) Metabolomics: A tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-From QSAR to QBAR. Mutation Res Genetic Toxicol Environ Mutagenesis 746(2):144\u2013150. https:\/\/doi.org\/10.1016\/j.mrgentox.2012.01.006","journal-title":"Mutation Res Genetic Toxicol Environ Mutagenesis"},{"key":"3638_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.yrtph.2016.09.013","volume":"81","author":"B van Ravenzwaay","year":"2016","unstructured":"van Ravenzwaay B, Sperber S, Lemke O, Fabian E, Faulhammer F, Kamp H, Mellert W, Strauss V, Strigun A, Peter E, Spitzer M, Walk T (2016) Metabolomics as read-across tool: a case study with phenoxy herbicides. Regul Toxicol Pharmacol 81:288\u2013304. https:\/\/doi.org\/10.1016\/j.yrtph.2016.09.013","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"3638_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1124\/dmd.121.000498","volume":"50","author":"NR Vansell","year":"2022","unstructured":"Vansell NR (2022) Mechanisms by which inducers of drug metabolizing enzymes alter thyroid hormones in rats. Drug metabolism and disposition. Am Soc Pharmacol Exp Therapy. 50(4):508\u2013517. https:\/\/doi.org\/10.1124\/dmd.121.000498","journal-title":"Am Soc Pharmacol Exp Therapy."},{"key":"3638_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10900-y","author":"MR Viant","year":"2019","unstructured":"Viant MR, Ebbels TMD, Beger RD, Ekman DR, Epps DJT, Kamp H, Leonards PEG, Loizou GD, MacRae JI, van Ravenzwaay B, Rocca-Serra P, Salek RM, Walk T, Weber RJM (2019) Use cases, best practice and reporting standards for metabolomics in regulatory toxicology. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-019-10900-y","journal-title":"Nat Commun"},{"key":"3638_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jat\/26.1.17","volume":"26","author":"H Yamada","year":"2002","unstructured":"Yamada H et al (2002) Dansyl chloride derivatization of methamphetamine: a method with advantages for screening and analysis of methamphetamine in urine. J Anal Toxicol 26:17\u201322","journal-title":"J Anal Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03638-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-023-03638-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-023-03638-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:13:57Z","timestamp":1708031637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-023-03638-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3638"],"URL":"https:\/\/doi.org\/10.1007\/s00204-023-03638-6","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}